Platelet size: Measurement, physiology and vascular disease

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 2, 1996, Pages 157-161

  Bath, P M W ^a   Butterworth, R J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetes mellitus; Hypercholesterolaemia; Hypertension; Myocardial infarction; Platelet volume; Pre eclampsia; Renal artery stenosis; Stroke

Indexed keywords

ASSAY; CONFERENCE PAPER; CONTROLLED STUDY; HEART INFARCTION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; PRIORITY JOURNAL; THROMBOCYTE SHAPE; THROMBOCYTE VOLUME;

EID: 0029888976     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199603000-00011     Document Type: Conference Paper

References (41)

1. Giles C. The platelet count and mean platelet volume. Br J Haematol 1981; 48: 31-37.
2. Trowbridge EA, Reardon DM, Hutchinson D, Pickering C. The routine measurement of platelet volume: a comparison of light-scattering and aperture-impedance technologies. Clin Phys Physiol Meas 1985; 6: 221-238.
3. Bath PMW. The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemostas 1993; 70: 687-690.
4. Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-1411.
5. Martin JF, Bath PMW. Platelets and megakaryocytes in vascular disease. In: Antithrombotics. Pathophysiological rationale for pharmacological interventions. Kluwer Academic Publishers, 1991; 49-62.
6. Sharp DS, Bath PMW, Martin JF, Sweetnam PM. Platelet and erythrocyte volume and count: epidemiological predictors of impedance measured ADP-induced platelet aggregation in whole blood. Platelets 1994; 5: 252-257.
7. Rao AK, Goldberg RE, Walsh PN. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume. J Lab Clin Med 1984; 103: 82-92.
8. Martin JF, Daniel TD, Trowbridge EA. Acute and chronic changes in platelet volume and count after cardiopulmonary bypass induced thrombocytopenia in man. Thromb and Haemostas 1987; 57: 1-4.
9. Martin JF. The relationship between megakaryocytes ploidy and platelet volume. Blood Cells 1989; 15: 108-117.
10. Kristensen SD, Bath PMW, Gladwin A-M, et al. The relationship between increased platelet count and megakaryocyte size in bronchial carcinoma. Br J Haematol 1992; 81: 247-251.
11. Bath PMW, Missouris CG, Buckenham T, MacGregor GA. Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis. Clin Sci 1994; 87: 253-257.
12. Brown AS, Hong Y, de Belder A, et al. Diabetics with peripheral vascular disease have an increased mean platelet volume and megakaryocyte ploidy. Br Heart J 1994; 71: 178 (abstract).
13. 51Cr labelled platelets in the sub-human primate. Thromb Res 1983; 30: 157-164.
14. Martin JF, Plumb J, Kilbey RS, Kishk YT. Changes in volume and density of platelets in myocardial infarction. Br Med J 1983; 287: 456-459.
15. Cameron HA, Philips R, Ibbotson RM, Carson PH. Platelet size in myocardial infarction. Br Med J 1983; 287: 449-451.
16. Kishk YT, Trowbridge EA, Martin JF. Platelet volume subpopulations in acute myocardial infarction: an investigation of homogeneity for smoking, infarct site and site. Clin Sci 1985; 68: 419-425.
17. Schultheiss HP, Tschoepe D, Esser J, et al. Large platelets continue to circulate in an activated state after myocardial infarction. Eur J Clin Invest 1994; 24: 243-247.
18. Hendra TJ, Oswald GA, Yudkin JS. Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes Res Clin Practice 1988; 5: 63-69.
19. Heptinstall S, Mulley GP, Taylor PM, Mitchell JRA. Platelet-release reaction in myocardial infarction. Br Med J 1980; i: 80-81.
20. Trip MD, Cats VM, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990; 322: 1549-1554.
21. Smyth DW, Martin JF, Michalis L, et al. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest 1993; 23: 361-367.
22. Bath PMW, Gladwin A-M, Carden N, Martin JF. Megakaryocyte DNA content is increased in patients with coronary artery atherosclerosis. Cardiovasc Res 1994; 28: 1348-1352.
23. Bath PMW, Blann AD, Watts GF. No association between serum platelet-derived growth factor, platelet size, and regression of angiographically-defined coronary heart disease. Platelets 1994; 5: 135-138.
24. D'Erasmo E, Aliberti G, Celi FS, et al. Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction. J Intern Med 1990; 227: 11-14.
25. O'Malley T, Langhorne P, Elton RA, Stewart C. Platelet size in stroke patients. Stroke 1995; 26: 995-999.
26. Uchiyama S, Takeuchi M, Osawa M, et al. Platelet function tests in thrombotic cerebrovascular disorders. Stroke 1983; 14: 511-517.
27. Tohgi H, Suzuki H, Tamura K, Kimura B. Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke 1991; 22: 17-21.
28. Lande K, Os I, Kjeldsen SE, et al. Increased platelet size and release reaction in essential hypertension. J Hypertension 1987; 5: 401-406.
29. Bath PMW, Carney C, Markandu ND, MacGregor GA. Platelet volume is not increased in essential hypertension. J Hum Hypertens 1994; 8: 457-459.
30. Cirillo M, Laurenzi M, and the Gubbio Study Collaborative Group. Erythrocyte and platelet volume in human hypertension. J Hypertension 1989; 7: S168-S169.
31. Prisco D, Rogasi PG, Paniccia R, et al. Altered lipid composition and thromboxane A2 formation in platelets from patients affected by IIa hyperlipoproteinemia. Thromb Res 1988; 50: 593-604.
32. Garg SK, Lackner H, Karpatkin S. The increased percentage of megathrombocytes in various clinical disorders. Ann Intern Med 1972; 77: 361-369.
33. Cagliero E, Porta M, Cousins S, Kohner EM. Increased platelet volume in diabetic retinopathy. Haemostasis 1982; 12: 293-299.
34. Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Quart J Med 1993; 86: 739-742.
35. Walker JJ, Cameron AD, Bjornsson S, et al. Can platelet volume predict progressive hypertensive disease in pregnancy? Am J Obstet Gynecol 1989; 161: 676-679.
36. Ahmed Y, van Iddekinge B, Paul C, et al. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol 1993; 100: 216-220.
37. Lande K, Kjeldsen SV, Eide I, et al. Does increased platelet release normalize during anti-hypertensive treatment? Thromb Haemostas 1987; 58: 834-838.
38. Gupta RK, Kjeldsen SE, Motley E, et al. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor. J Cardiovasc Pharm 1991; 17: 13-19.
39. Broijersen A, Eriksson M, Larsson PT, et al. Effects of selective LDL-apheresis and pravastatin therapy on platelet function in familial hypercholesterolaemia. Eur J Clin Invest 1994; 24: 488-498.
40. Bath PMW, Cappuccio FP, Singer DJ, et al. A high salt intake is associated with an increase in platelet size: a further risk factor for vascular disease. Nutr Metab Cardiovasc Dis 1995; 5: 71-74.
41. Bath PMW, Butterworth RJ. Platelet size in vascular disease. Eur J Clin Invest 1995; 25: A34.